Ethyl 6-cyano-2-oxohexanoate, 96.0%, 2g

Octan-2-ol, 95.0%, 5g

2-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclopropanecarboxylic acid, 97%, 100mg

(R)-2-(2-(Diphenylphosphanyl)phenyl)-4-isopropyl-5,5-diphenyl-4,5-dihydrooxazole, 98%, 1g

tert-butyl (2S)-2-[4-(3-bromophenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 95%, 10g

(5-Amino-tetrazol-2-yl)-acetic acid, 1g

(4-aminobutyl)(diazyn-1-ium-1-yl)azanide hydrochloride, 98%, 100mg

Proteinase K, 500 mg, in 30 ml glass vial

2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one, 95.0%, 1g

tert-Butyl (2-nitrophenyl)sulfonylcarbamate, 95.0%, 25g

(R)-3-Cbz-2-Oxo-imidazolidine-4-carboxylic acid, 95.0%, 250mg

2-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid, 95.0%, 5g

6-fluoro-1,3-benzoxazol-2(3H)-one, 95.0%, 1g